Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmad Awada

Showing results (71-80 of 311) with videos related to

Pageof 32
Sort By:
Clinical Colorectal Cancer|January 27, 2010
Is tailored adjuvant treatment for colon cancer possible?Marc Van den Eynde, Ahmad Awada, Alain Hendlisz
Current Opinion in Oncology|July 24, 2019
How to assimilate the tsunami of immune checkpoints inhibitors data into clinical practice?Luís Castelo-Branco, Sandrine Aspeslagh, Nuria Kotecki, et al.
Current Opinion in Oncology|April 7, 2007
Clinical trial design limitations in head and neck squamous cell carcinomasHwan Jung Yun, Jan Bogaerts, Ahmad Awada, et al.
Cancer Treatment Reviews|April 26, 2005
Adjuvant anthracycline-based chemotherapy for early breast cancer: do the dose and schedule matter?Max S Mano, Ahmad Awada, Janet Kerr, et al.
Clinical and Experimental Rheumatology|June 15, 2021
Soluble ST2 is increased in systemic lupus erythematous and is a potential marker of lupus nephritisAnthony Moreau, Charles Nicaise, Ahmad Awada, et al.
Bulletin Du Cancer|April 9, 2008
[HER2 and topoisomerase II alpha: useful clinical markers in breast cancer]Denis Larsimont, Virginie Durbecq, Ahmad Awada, et al.
Cancer Treatment Reviews|January 24, 2017
The immune infiltrate in prostate, bladder and testicular tumors: An old friend for new challengesCinzia Solinas, Nieves Martinez Chanzá, Ahmad Awada, et al.
European Journal of Case Reports in Internal Medicine|February 15, 2021
Rare Features of Dermatomyositis in a Patient with Ovarian CancerLissandra Dal Lago, Frédéric Vandergheynst, Ahmad Awada, et al.
Current Opinion in Oncology|June 3, 2026
From dose to exposure? rethinking fluoropyrimidines as immune checkpoint partners in gastrointestinal cancersAlain Hendlisz, Leila Shaza, Thierry De Grez, et al.
Current Opinion in Oncology|May 3, 2017
Controversies about fertility and pregnancy issues in young breast cancer patients: current state of the artMatteo Lambertini, Oranite Goldrat, Florian Clatot, et al.
Pageof 32

Showing results (71-80 of 311) with videos related to

Sort By:
Pageof 32
Clinical Colorectal Cancer|January 27, 2010
Is tailored adjuvant treatment for colon cancer possible?Marc Van den Eynde, Ahmad Awada, Alain Hendlisz
Current Opinion in Oncology|July 24, 2019
How to assimilate the tsunami of immune checkpoints inhibitors data into clinical practice?Luís Castelo-Branco, Sandrine Aspeslagh, Nuria Kotecki, et al.
Current Opinion in Oncology|April 7, 2007
Clinical trial design limitations in head and neck squamous cell carcinomasHwan Jung Yun, Jan Bogaerts, Ahmad Awada, et al.
Cancer Treatment Reviews|April 26, 2005
Adjuvant anthracycline-based chemotherapy for early breast cancer: do the dose and schedule matter?Max S Mano, Ahmad Awada, Janet Kerr, et al.
Clinical and Experimental Rheumatology|June 15, 2021
Soluble ST2 is increased in systemic lupus erythematous and is a potential marker of lupus nephritisAnthony Moreau, Charles Nicaise, Ahmad Awada, et al.
Bulletin Du Cancer|April 9, 2008
[HER2 and topoisomerase II alpha: useful clinical markers in breast cancer]Denis Larsimont, Virginie Durbecq, Ahmad Awada, et al.
Cancer Treatment Reviews|January 24, 2017
The immune infiltrate in prostate, bladder and testicular tumors: An old friend for new challengesCinzia Solinas, Nieves Martinez Chanzá, Ahmad Awada, et al.
European Journal of Case Reports in Internal Medicine|February 15, 2021
Rare Features of Dermatomyositis in a Patient with Ovarian CancerLissandra Dal Lago, Frédéric Vandergheynst, Ahmad Awada, et al.
Current Opinion in Oncology|June 3, 2026
From dose to exposure? rethinking fluoropyrimidines as immune checkpoint partners in gastrointestinal cancersAlain Hendlisz, Leila Shaza, Thierry De Grez, et al.
Current Opinion in Oncology|May 3, 2017
Controversies about fertility and pregnancy issues in young breast cancer patients: current state of the artMatteo Lambertini, Oranite Goldrat, Florian Clatot, et al.
Pageof 32